Trial Profile
Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Aug 2021
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel (Primary) ; Cisplatin; Gemcitabine
- Indications Urogenital cancer
- Focus Therapeutic Use
- 05 Aug 2021 Status changed from not yet recruiting to completed.
- 06 Jan 2021 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Jan 2019).
- 15 Feb 2017 New trial record